Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma.

MLA

Liu, Zhiqian, et al. “Targeting FAM134B-Mediated Reticulophagy Activates Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.” Biochemical and Biophysical Research Communications, vol. 589, Jan. 2022, pp. 247–53. EBSCOhost, https://doi.org/10.1016/j.bbrc.2021.12.019.

APA

Liu, Z., Ma, C., Wang, Q., Yang, H., Lu, Z., Bi, T., Xu, Z., Li, T., Zhang, L., Zhang, Y., Liu, J., Wei, X., & Li, J. (2022). Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma. Biochemical and Biophysical Research Communications, 589, 247–253. https://doi.org/10.1016/j.bbrc.2021.12.019

Chicago

Liu, Zhiqian, Changlin Ma, Qi Wang, Hao Yang, Zhihua Lu, Tao Bi, Zongzhen Xu, et al. 2022. “Targeting FAM134B-Mediated Reticulophagy Activates Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.” Biochemical and Biophysical Research Communications 589 (January): 247–53. doi:10.1016/j.bbrc.2021.12.019.